Use of molecular markers for predicting therapy response in cancer patients
- 1 April 2011
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 37 (2), 151-159
- https://doi.org/10.1016/j.ctrv.2010.07.004
Abstract
No abstract availableKeywords
Funding Information
- Health Research Board (CSA/2007/11)
This publication has 105 references indexed in Scilit:
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trialThe Lancet Oncology, 2009
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009
- Biological determinants of endocrine resistance in breast cancerNature Reviews Cancer, 2009
- Gene-Expression Signatures in Breast CancerNew England Journal of Medicine, 2009
- The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancerBreast Cancer Research and Treatment, 2009
- Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancerThe Lancet Oncology, 2008
- Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifenBreast Cancer Research and Treatment, 2008
- Epidermal growth factor receptor mutations in lung cancerNature Reviews Cancer, 2007
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsCancer Cell, 2004